Literature DB >> 24923209

Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapy in vitro.

Ina Albert, Martin Hefti, Vera Luginbuehl.   

Abstract

OBJECTIVES: The partial pressure of oxygen (pO2) in brain tumors ranges from 5 to 15%. Nevertheless, the majority of in vitro experiments with glioblastoma multiforme (GBM) cell lines are carried out under an atmospheric pO2 of 19 to 21%. Recently, 5-aminolevulinic acid (5-ALA), a precursor of protoporphyrin IX (PpIX), has been introduced to neurosurgery to allow for photodynamic diagnosis and photodynamic therapy (PDT) in high-grade gliomas. Here, we investigate whether low pO2 affects GBM cell physiology, PpIX accumulation, or PDT efficacy.
METHODS: GBM cell lines (U-87 MG and U-251 MG) were cultured under atmospheric (pO2  =  19%) and physiological (pO2  =  9%) oxygen concentrations. PpIX accumulation and localization were investigated, and cell survival and cell death were observed following in vitro PDT.
RESULTS: A physiological pO2 of 9% stimulated GBM cell migration, increased hypoxia-inducible factor (HIF)-1 alpha levels, and elevated resistance to camptothecin in U-87 MG cells compared to cultivation at a pO2 of 19%. This oxygen reduction did not alter 5-ALA-induced intracellular PpIX accumulation. However, physiological pO2 changed the responsiveness of U-87 MG but not of U-251 MG cells to in vitro PDT. Around 20% more irradiation light was required to kill U-87 MG cells at physiological pO2, resulting in reduced lactate dehydrogenase (LDH) release (one- to two-fold) and inhibition of caspase 3 activation. DISCUSSION: Reduction of oxygen concentration from atmospheric to a more physiological level can influence the malignant behavior and survival of GBM cell lines after in vitro PDT. Therefore, precise oxygen concentration control should be considered when designing and performing experiments with GBM cells.

Entities:  

Keywords:  5-Aminolevulinic acid,; Glioblastoma,; Migration,; Photodynamic therapy,; Physiological oxygen concentration

Mesh:

Substances:

Year:  2014        PMID: 24923209     DOI: 10.1179/1743132814Y.0000000401

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  11 in total

1.  Photodithazine photodynamic effect on viability of 9L/lacZ gliosarcoma cell line.

Authors:  Leticia C Fontana; Juliana G Pinto; André H C Pereira; Cristina P Soares; Leandro J Raniero; Juliana Ferreira-Strixino
Journal:  Lasers Med Sci       Date:  2017-05-15       Impact factor: 3.161

Review 2.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

3.  Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.

Authors:  Cheng-Shi Xu; Ze-Fen Wang; Xiao-Dong Huang; Li-Ming Dai; Chang-Jun Cao; Zhi-Qiang Li
Journal:  J Transl Med       Date:  2015-03-20       Impact factor: 5.531

4.  Perfluorocarbon-Loaded Lipid Nanocapsules to Assess the Dependence of U87-Human Glioblastoma Tumor pO2 on In Vitro Expansion Conditions.

Authors:  Laurent Lemaire; Janske Nel; Florence Franconi; Guillaume Bastiat; Patrick Saulnier
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

5.  HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.

Authors:  Pan Wang; Chuan Lan; Shuanglong Xiong; Xiuwen Zhao; You'an Shan; Rong Hu; Wenwu Wan; Shuangjiang Yu; Bin Liao; Guangzhi Li; Junwei Wang; Dewei Zou; Bing Chen; Hua Feng; Nan Wu
Journal:  Oncotarget       Date:  2017-04-25

6.  MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1α-FECH axes.

Authors:  Vipin Shankar Chelakkot; Kaiwen Liu; Ema Yoshioka; Shaykat Saha; Danyang Xu; Maria Licursi; Ann Dorward; Kensuke Hirasawa
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

Review 7.  Molecular and Metabolic Mechanisms Underlying Selective 5-Aminolevulinic Acid-Induced Fluorescence in Gliomas.

Authors:  Jeffrey I Traylor; Mark N Pernik; Alex C Sternisha; Samuel K McBrayer; Kalil G Abdullah
Journal:  Cancers (Basel)       Date:  2021-02-02       Impact factor: 6.639

8.  Monitoring Tumor Hypoxia Using (18)F-FMISO PET and Pharmacokinetics Modeling after Photodynamic Therapy.

Authors:  Xiao Tong; Avinash Srivatsan; Orit Jacobson; Yu Wang; Zhantong Wang; Xiangyu Yang; Gang Niu; Dale O Kiesewetter; Hairong Zheng; Xiaoyuan Chen
Journal:  Sci Rep       Date:  2016-08-22       Impact factor: 4.379

9.  Transcriptional Repression of p53 by PAX3 Contributes to Gliomagenesis and Differentiation of Glioma Stem Cells.

Authors:  Hui Zhu; Hongkui Wang; Qingfeng Huang; Qianqian Liu; Yibing Guo; Jingjing Lu; Xiaohong Li; Chengbin Xue; Qianqian Han
Journal:  Front Mol Neurosci       Date:  2018-06-08       Impact factor: 5.639

Review 10.  Systematic Review and Meta-Analysis of In Vitro Anti-Human Cancer Experiments Investigating the Use of 5-Aminolevulinic Acid (5-ALA) for Photodynamic Therapy.

Authors:  Yo Shinoda; Daitetsu Kato; Ryosuke Ando; Hikaru Endo; Tsutomu Takahashi; Yayoi Tsuneoka; Yasuyuki Fujiwara
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.